Newbridge Financial Services Group, Inc. Mereo Biopharma Group PLC Transaction History
Newbridge Financial Services Group, Inc.
- $633 Million
- Q4 2025
A detailed history of Newbridge Financial Services Group, Inc. transactions in Mereo Biopharma Group PLC stock. As of the latest transaction made, Newbridge Financial Services Group, Inc. holds 17,000 shares of MREO stock, worth $30,940. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,000
Previous 13,000
30.77%
Holding current value
$30,940
Previous $25,000
20.0%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding MREO
# of Institutions
95Shares Held
94.9MCall Options Held
2.23MPut Options Held
179K-
Janus Henderson Group PLC London, X016.3MShares$29.6 Million0.02% of portfolio
-
Rubric Capital Management LP New York, NY15.3MShares$27.9 Million0.5% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA9.44MShares$17.2 Million0.79% of portfolio
-
Mangrove Partners New York, NY7.79MShares$14.2 Million1.99% of portfolio
-
683 Capital Management, LLC New York, NY4.88MShares$8.87 Million0.57% of portfolio
About Mereo Biopharma Group plc
- Ticker MREO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,986,000
- Market Cap $227M
- Description
- Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...